Kyung Dong Pharmaceutical Co. Ltd Capital Reinvestment Ratio
Kyung Dong Pharmaceutical Co. Ltd capital reinvestment ratio. Kyung Dong Pharmaceutical Co. Ltd (011040) has a Capital Reinvestment Ratio of 0.18x as of June 2026, meaning it reinvests 0% of its operating cash flow (₩4.75 Billion) in capital expenditures (₩842.84 Million). Check 011040 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Kyung Dong Pharmaceutical Co. Ltd (2011–2025)
Capital reinvestment ratio of Kyung Dong Pharmaceutical Co. Ltd from 2011 to 2025. This chart tracks Kyung Dong Pharmaceutical Co. Ltd's Capital Reinvestment Ratio across 11 annual periods. Also explore 011040 net asset momentum to track the company's year-over-year net asset growth rate.
Kyung Dong Pharmaceutical Co. Ltd Capital Reinvestment Ratio by Year (2011–2025)
Kyung Dong Pharmaceutical Co. Ltd capital reinvestment ratio by year from 2011 to 2025. For the full cash flow conversion analysis, see Kyung Dong Pharmaceutical Co. Ltd cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.21x | ₩16.93 Billion | ₩20.51 Billion | ▲ +283.3% |
| 2021 | 0.32x | ₩12.42 Billion | ₩3.93 Billion | ▼ -81.1% |
| 2020 | 1.67x | ₩17.12 Billion | ₩28.59 Billion | ▲ +1313.5% |
| 2018 | 0.12x | ₩33.27 Billion | ₩3.93 Billion | ▼ -69.6% |
| 2017 | 0.39x | ₩14.79 Billion | ₩5.74 Billion | ▲ +38.3% |
| 2016 | 0.28x | ₩25.63 Billion | ₩7.19 Billion | ▼ -53.8% |
| 2015 | 0.61x | ₩18.26 Billion | ₩11.10 Billion | ▼ -34.8% |
| 2014 | 0.93x | ₩22.73 Billion | ₩21.17 Billion | ▲ +63.0% |
| 2013 | 0.57x | ₩16.42 Billion | ₩9.38 Billion | ▲ +61.4% |
| 2012 | 0.35x | ₩19.96 Billion | ₩7.06 Billion | ▲ +277.9% |
| 2011 | 0.09x | ₩26.08 Billion | ₩2.44 Billion | — |